Epigallocatechin-3-Gallate attenuates lipopolysacharide-induced pneumonia via modification of inflammation, oxidative stress, apoptosis, and autophagy
Article in BMC Complementary Medicine and Therapies (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in BMC Complementary Medicine and Therapies (April 2024)
Article in Journal of Thoracic Disease (December 2023)
Article in Molecules (August 2023)